1Manns M, sigler MH. TeehanBp.Continuos renal replacement therapies:an update. Am J Kidney Dis, 1998,32(2): 185.
2Schetz MRC. CLassical and alternative indication for Continuous renal replacementtherapy. Kidney Int, 1998.53(Supp166): 129.
3Tetta C, Mariano F, Ronco C, et al. Relevance of plateleactivating factor ininflammation and Sepsis: Mechnisms and Kidney removal in extracorporeal treatment. Am JKidney Dis, 1997, 30(5supp14): S57.
3Bone R.Immunologic dissonance:a continuing evolution in our understanding of the systermic inflammatory response syndroms and the multiple organ dysfunction syndrome,1996.
4Giovani C;Claudio R;Giuseppe M.Role of soluble mediators in sepsis and renal failure,1998.
5Breen D;Bihari D.Acute renal failure as a part of multiple organ failure:The slippery slope of critical illness,1998(Suppl).
6Vrise;Colarayn FA;philippe JJ.Cytokine removal during continuous hemofiltration in septic patients,1999.
7Kuo SR,Willingham MC,Bout SH,et al. Anthrax toxin-inducedshockin rats is associated with pulmonary edema and hemorrhage[J].Microb Pathog,2008,44(6) :467472.
8Cunnington A, Nadel S. New therapies for sepsis[ J]. Curt TopMed Chem,2008,8(7) :603-614.
